GERN - Geron Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

4.01

+0.22 (+5.80%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	3.79
Open	3.80
Bid	0.00 x 0
Ask	0.00 x 0
Day's Range	3.75 - 4.20
52 Week Range	1.74 - 6.68
Volume	7,605,106
Avg. Volume	7,364,893

Market Cap	644.223M
Beta	2.35
PE Ratio (TTM)	N/A
EPS (TTM)	-0.18
Earnings Date	May 4, 2017 - May 8, 2017
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	5.50

Trade prices are not sourced from all markets

All

News

Press Releases

Yahoo Finance Video5 days ago
NYSE trader: Stocks are rallying on fundamentals and not the finger pointing in DC
Matthew Cheslock joins Yahoo Finance's Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
CNBC Videos7 days ago
Cramer's lightning round: Take a long-term view on Spotif...
Jim Cramer shares his take on callers' favorite stocks at lightning speed, including a newly public streaming play.
Yahoo Finance Video7 days ago
MARKETS: These are the top risks CEOs are citing this earnings season
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance Video12 days ago
MARKETS: Bitcoin shorts obliterated on 11% surge
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.
Yahoo Finance Video13 days ago
MARKETS: Welcome to the low volume, low liquidity algo-driven market
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance Video20 days ago
MARKETS: Bulls need to avoid a closing bell selloff today
Yahoo Finance's Jared Blikre joins Seana Smith from the floor of the New York Stock Exchange to discuss the latest market moves.
Yahoo Finance Video22 days ago
MARKETS: Why April could be a bad month for stocks
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.
Motley Fool15 hours ago
Geron Corporation: The Clock Is Ticking
Geron's stock has been a magnet for short-sellers, but the long thesis remains intact.
Motley Fool6 days ago
Why Geron Corporation's Stock Is Heading Higher Today
Geron's experimental blood cancer drug remains a top priority for the pharma behemoth Johnson & Johnson.
GlobeNewswire7 days ago
Geron 2018 Annual Meeting of Stockholders to be Held on May 15
MENLO PARK, Calif., April 17, 2018-- Geron Corporation will hold its 2018 Annual Meeting of Stockholders, on Tuesday, May 15, 2018, at 4:00 p.m. PDT.. Geron’ s stockholders are invited to attend the Annual ...
Zacks8 days ago
Why Is Geron (GERN) Up 10.6% Since Its Last Earnings Report?
Geron (GERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks11 days ago
Here's Why Geron Stock Surged More Than 90% in 6 Months
Geron (GERN) telomerase inhibitor, imetelstat, is being evaluated in two late stage studies. The candidate is progressing well in the Janssen sponsored studies.
ACCESSWIRE11 days ago
Today’s Research Reports on Stocks to Watch: Geron Corp. and Rigel Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / April 13, 2018 / Rigel shares were popping on Thursday but unfortunately it was due to a mistake. The company corrected the mistake after-hours and announced that there had ...
Motley Fool11 days ago
Why Geron Corporation Stock Popped 84% in March
The small-cap oncology biotech's stock is likely to see big movement next week.
Simply Wall St.11 days ago
Should You Worry About Geron Corporation’s (NASDAQ:GERN) CEO Pay Check?
Chip Scarlett took the reins as CEO of Geron Corporation’s (NASDAQ:GERN) and grew market cap to US$531.76M recently. Recognizing whether CEO incentives are aligned with shareholders is a crucial partRead More...
Motley Fool12 days ago
Why Geron Corporation Stock Is on the Rise Today
Geron's shares are on the move again today. Here's why.
Motley Fool15 days ago
3 Reasons This Clinical-Stage Biotech Is an Incredible Bargain
Geron's risk-to-reward ratio might be too juicy to pass up.
ACCESSWIRE18 days ago
GERON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Geron Corporation To Contact The Firm
NEW YORK, NY / ACCESSWIRE / April 5, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Geron Corporation ("Geron" or the "Company") ...
Business Wire20 days ago
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Geron Corporation Investors (GERN)
Glancy Prongay & Murray LLP announces an investigation on behalf of Geron Corporation investors concerning the Company and its officers’ possible violations of federal securities laws.
Business Wire20 days ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Geron Corporation
Levi & Korsinsky announces it has commenced an investigation of Geron Corporation concerning possible violations of federal securities laws.
Motley Fool22 days ago
Why Geron Corporation Stock Is Falling Today
Geron's stock can't seem to find a bottom.
Motley Fool22 days ago
Are Short-Sellers Right About Geron Corporation?
The short argument against Geron doesn't add up. Here's why.
Motley Fool25 days ago
Geron Corp. Skyrocketed and AbbVie Inc. Crashed -- Are These Stocks Buys?
Geron’s future hinges on an uncertainty and AbbVie’s teetering following disappointing news. Do these stocks deserve a place in your portfolio?
ACCESSWIRE25 days ago
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Geron Corporation
LOS ANGELES, CA / ACCESSWIRE / March 29, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Geron Corporation ...
Motley Fool26 days ago
These 3 Biotech Stocks Are Soaring, but Are They Buys Now?
These highfliers could could climb higher. Here's what needs to happen.